Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.

[1]  D. Ross,et al.  A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters. , 1997, Journal of neuropathology and experimental neurology.

[2]  M. Seto,et al.  Cyclin D1 over expression in malignant lymphomas , 1997, Pathology international.

[3]  J. Parisi,et al.  Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990. , 1997, Journal of neurosurgery.

[4]  M. Melamed,et al.  Laser scanning cytometric analysis of cyclin B1 in primary human malignancies. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[5]  J. Rutka,et al.  Current concepts in neuro-oncology: the cell cycle--a review. , 1997, Neurosurgery.

[6]  B. Scheithauer,et al.  Classification and Grading of Low‐Grade Astrocytic Tumors in Children , 1997, Brain pathology.

[7]  D. Louis.  A Molecular Genetic Model of Astrocytoma Histopathology , 1997, Brain pathology.

[8]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[9]  L. R. Bridges,et al.  Cyclin D1 in astrocytic tumours: an immunohistochemical study , 1996, Neuropathology and applied neurobiology.

[10]  J. Brockmöller,et al.  p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. , 1996, Human pathology.

[11]  B. Scheithauer,et al.  THE MIB-1 LI IN PILOCYTIC AND DIFFUSE ASTROCYTOMAS , 1996 .

[12]  H. Wakimoto,et al.  Prognostic significance of Ki‐67 labeling indices obtained using MIB‐1 monoclonal antibody in patients with supratentorial astrocytomas , 1996, Cancer.

[13]  D. Schofield,et al.  Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. , 1995, Human pathology.

[14]  A. Hart,et al.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.

[15]  J. Bartek,et al.  Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. , 1995, Oncogene.

[16]  T. Visakorpi,et al.  Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples , 1994, The Journal of pathology.

[17]  Charles B. Wilson,et al.  Correlation between the bromodeoxyuridine labeling index and the MIB‐1 and Ki‐67 proliferating cell indices in cerebral gliomas , 1994, Cancer.

[18]  B. Scheithauer,et al.  The Significance of Atypia and Histologic Malignancy in Pilocytic Astrocytoma of the Cerebellum: A Clinicopathologic and Flow Cytometric Study , 1994, Journal of child neurology.

[19]  N. Colombo,et al.  Leptomeningeal dissemination of juvenile pilocytic astrocytoma: case report. , 1994, Surgical neurology.

[20]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[21]  J. A. Marchosky,et al.  Cell kinetic classification of tumors of the nervous system by DNA precursor labeling in vitro. , 1993, Human pathology.

[22]  J. Goldblum,et al.  Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[23]  A. Papanikolaou,et al.  Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections. , 1993, The American journal of surgical pathology.

[24]  B. Scheithauer,et al.  Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients , 1993, Cancer.

[25]  B. Scheithauer,et al.  Astrocytomas of the cerebellum: A comparative clinicopathologic study of pilocytic and diffuse astrocytomas , 1993, Cancer.

[26]  P. Hall,et al.  Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1 , 1993, Histopathology.

[27]  K. Keyomarsi,et al.  Redundant cyclin overexpression and gene amplification in breast cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Funata,et al.  Leptomeningeal dissemination of cerebellar pilocytic astrocytoma. Case report. , 1992, Journal of neurosurgery.

[29]  S. Vandenberg.  Current Diagnostic Concepts of Astrocytic Tumors , 1992, Journal of neuropathology and experimental neurology.

[30]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[31]  M. Prados,et al.  Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling. , 1992, Neurosurgery.

[32]  R. Davis,et al.  Metastatic juvenile pilocytic astrocytoma. Case report. , 1991, Journal of neurosurgery.

[33]  C. Daumas-Duport,et al.  Radiation therapy in the management of low-grade supratentorial astrocytomas. , 1989, Journal of neurosurgery.

[34]  P. Mckeever,et al.  Cerebral pilocytic astrocytoma , 1985, Cancer.

[35]  R. Tubbs,et al.  Immunohistology of lymphoproliferative disorders. , 1984, Seminars in diagnostic pathology.

[36]  J. Mclaughlin,et al.  Juvenile astrocytomas with subarachnoid spread , 1976, The Journal of pathology.

[37]  J. Kepes,et al.  Late malignant recurrence of childhood cerebellar astrocytoma. Report of two cases. , 1972, Journal of neurosurgery.

[38]  N. Ragni,et al.  Expression of cyclin D1 correlates with malignancy in human ovarian tumours. , 1997, British Journal of Cancer.

[39]  K. Zulch.  Histologic typing of tumours of the central nervous system , 1979 .